Results 221 to 230 of about 99,561 (320)

Lung Surfactant Deficiency in Severe Respiratory Failure: A Potential Biomarker for Clinical Assessment. [PDF]

open access: yesDiagnostics (Basel)
Schousboe P   +8 more
europepmc   +1 more source

Network Pharmacology and Experimental Validation Reveal Ganodermanontriol Modulates Pneumonia via TNF/NF‐κB/MAPKs Signaling Pathway

open access: yesFood Science &Nutrition, Volume 13, Issue 4, April 2025.
Ganodermanontriol, the primary triterpenoid identified in Ganoderma lucidum, was evaluated for its efficacy against pneumonia through network pharmacology, molecular docking, and in vivo rat models. The compound significantly reduced lung tissue damage and inflammatory mediators by targeting the TNF/NF‐κB/MAPKs signaling pathways.
Shizhan Deng   +9 more
wiley   +1 more source

Deciphering Oxygenation Metrics in ARDS: A Deep Dive into the OXIVA-CARDS Study. [PDF]

open access: yesIndian J Crit Care Med
Gangireddy S, Kambagiri P, Jindal A.
europepmc   +1 more source

Hemoperfusion Combined With Continuous Renal Replacement Therapy in the Management of ARDS COVID‐19 Patients: A Quasi‐Experimental Study

open access: yesHealth Science Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background and Aims Critically ill patients in COVID‐19 to the intensive care unit (ICU) may develop multiple organ dysfunction syndrome, with some requiring extracorporeal organ support. This study aimed to assess the effects of combined CytoSorb hemoperfusion (HP) and continuous renal replacement therapy (CRRT) on the improvement of the ...
Seyed MohammadReza Hashemian   +4 more
wiley   +1 more source

Significance of Neurological Manifestations and Their Association With Clinical Outcomes in Hospitalized COVID‐19 Patients in Bandar Abbas, Iran: A Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background Neurological manifestations are increasingly recognized in COVID‐19 patients, yet their prevalence and clinical significance remain understudied. This study aimed to determine the incidence and significance of neurological symptoms and their associations with demographic, clinical, and laboratory parameters in hospitalized COVID‐19 ...
Ahmadagha Negahi   +5 more
wiley   +1 more source

MSC-mediated mitochondrial transfer promotes metabolic reprograming in endothelial cells and vascular regeneration in ARDS. [PDF]

open access: yesRedox Rep
Wang J   +11 more
europepmc   +1 more source

Effectiveness and Safety of Simnotrelvir/Ritonavir and Nirmatrelvir/Ritonavir in the Treatment of Moderate to Severe COVID‐19

open access: yesImmunity, Inflammation and Disease, Volume 13, Issue 4, April 2025.
This is the first study comparing the effectiveness of simnotrelvir/ritonavir and nirmatrelvir/ritonavir in treating moderate and severe COVID‐19 patients. Patients who received simnotrelvir/ritonavir exhibited shorter hospitalization. Disease progression, viral clearance times, and symptom resolution time were similar between the two groups.
Xin Chen   +7 more
wiley   +1 more source

Total bilirubin as a marker for hemolysis and outcome in patients with severe ARDS treated with veno-venous ECMO. [PDF]

open access: yesBMC Anesthesiol
Bünger V   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy